These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3034739)

  • 1. ACE-inhibitors in the treatment of elderly hypertensives.
    M'Buyamba-Kabangu JR; Fagard R; Lijnen P; Staessen J; Van Hoof R; Amery A
    Geriatrics; 1987 Jun; 42(6):45-9. PubMed ID: 3034739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of angiotensin-converting enzyme inhibitors in hypertension].
    Rahn KH
    Z Kardiol; 1988; 77 Suppl 3():69-71. PubMed ID: 2850690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical experience with converting-enzyme inhibitors in hypertension.
    Weber MA
    Am J Kidney Dis; 1987 Jul; 10(1 Suppl 1):45-51. PubMed ID: 3037889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Converting enzyme inhibitors in the treatment of elderly hypertensives.
    Amery A; Van Hoof R; Bielen E; Fagard R; Staessen J; Thijs L; Vanhees L
    Acta Cardiol; 1989; 44(4):269-87. PubMed ID: 2552717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of angiotensin-converting-enzyme inhibitors in combination with diuretics on blood pressure and renal injury in nitric oxide-deficiency-induced hypertension in rats.
    García-Estañ J; Ortiz MC; O'Valle F; Alcaraz A; Navarro EG; Vargas F; Evangelista S; Atucha NM
    Clin Sci (Lond); 2006 Feb; 110(2):227-33. PubMed ID: 16197366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Superior effect of an angiotensin-converting enzyme inhibitor over a diuretic for reducing aortic systolic pressure.
    Jiang XJ; O'Rourke MF; Zhang YQ; He XY; Liu LS
    J Hypertens; 2007 May; 25(5):1095-9. PubMed ID: 17414675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mechanisms of action and clinical use of converting enzyme inhibitors].
    Lazowski J; Rewerski W
    Pol Tyg Lek; 1986 Dec; 41(48):1507-11. PubMed ID: 3035518
    [No Abstract]   [Full Text] [Related]  

  • 8. Overview: the role of angiotensin-converting enzyme inhibitors in cardiovascular therapy.
    Abrams WB; Davies RO; Ferguson RK
    Fed Proc; 1984 Apr; 43(5):1314-21. PubMed ID: 6323221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy and safety of enalapril in moderate to severe essential hypertension.
    Walker JF; Kulaga SF; Kramsch DM
    J Hypertens Suppl; 1984 Dec; 2(2):S107-11. PubMed ID: 6100871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age-related effects of angiotensin converting enzyme inhibitors.
    Breckenridge A
    J Cardiovasc Pharmacol; 1988; 12 Suppl 8():S100-4. PubMed ID: 2469889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular events in elderly patients with isolated systolic hypertension. A subgroup analysis of treatment strategies in STOP-Hypertension-2.
    Ekbom T; Linjer E; Hedner T; Lanke J; De Faire U; Wester PO; Dahlöf B; Scherstén B
    Blood Press; 2004; 13(3):137-41. PubMed ID: 15223721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Converting-enzyme inhibitors in the treatment of elderly hypertension patients].
    Amery A; Buyamba-Kabangu JR; Fagard R; Lijnen P; Staessen J; van Hoof R
    Wien Med Wochenschr; 1990 Jan; 140(1-2):30-4. PubMed ID: 2408248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of angiotensin-converting enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPP) randomized trial. The Captopril Prevention Project (CAPP) Study Group.
    Curr Hypertens Rep; 1999 Dec; 1(6):466-7. PubMed ID: 11041675
    [No Abstract]   [Full Text] [Related]  

  • 14. Should the use of short acting angiotensin-converting enzyme inhibitors be abandoned?
    Erman A; Boner G; van Dijk DJ
    J Renin Angiotensin Aldosterone Syst; 2000 Dec; 1(4):365-8. PubMed ID: 11967825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ACE inhibitors as initial therapy for hypertension.
    Schoenberger JA
    Am Fam Physician; 1988 Apr; 37(4):139-46. PubMed ID: 3282415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of captopril-enalapril replacement therapy in hypertensive patients under ambulatory blood pressure monitoring].
    Ruszty L; Hidas I; Iványi J; Dudás M; Molnár S
    Orv Hetil; 1996 Dec; 137(51):2851-4. PubMed ID: 9679620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Inhibitors of angiotensin-converting enzyme in cardiac insufficiency].
    Amodeo C
    Arq Bras Cardiol; 1990 Feb; 54(2):97-9. PubMed ID: 2175595
    [No Abstract]   [Full Text] [Related]  

  • 18. High prevalence of persistent cough with angiotensin converting enzyme inhibitors in Chinese.
    Woo KS; Nicholls MG
    Br J Clin Pharmacol; 1995 Aug; 40(2):141-4. PubMed ID: 8562296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An overview of angiotensin-converting enzyme inhibitors in the treatment of hypertension.
    Weber MA
    J Am Osteopath Assoc; 1987 Feb; 87(2 Suppl):175-80. PubMed ID: 3030978
    [No Abstract]   [Full Text] [Related]  

  • 20. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.